Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

Rigshospitalet, Copenhagen

Weill Cornell Medical Center, New York

Moffitt Cancer Center, Tampa

Sarah Cannon Research Institute, Nashville

The Ohio State University, Columbus

Gabrail Cancer Center Research, Canton

Washington University School of Medicine, St Louis

MD Anderson Cancer Center, Houston

Dana-Farber Cancer Institute, Boston

Hackensack University Medical Center, Hackensack

Tom Baker Cancer Centre, Calgary

Princess Margaret Hospital, Toronto